Charles Keller Reid, a director at $BLBX, sold 5,000 shares of the company on 10-21-2025 for an estimated $46,175. We received data on the trade from a recent SEC filing. This was a sale of approximately 23.5% of their shares of this class of stock. Following this trade, they now own 16,298 shares of this class of $BLBX stock.
$BLBX Insider Trading Activity
$BLBX insiders have traded $BLBX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $BLBX stock by insiders over the last 6 months:
- CHARLES BRANDON SMITH (Chief Technology Officer) sold 9,167 shares for an estimated $83,191
- CHARLES KELLER REID sold 5,000 shares for an estimated $46,175
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BLBX Hedge Fund Activity
We have seen 6 institutional investors add shares of $BLBX stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC added 37,645 shares (+inf%) to their portfolio in Q2 2025, for an estimated $221,729
- SCIENTECH RESEARCH LLC removed 12,811 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $75,456
- CORIENT PRIVATE WEALTH LLC added 10,531 shares (+inf%) to their portfolio in Q2 2025, for an estimated $62,027
- SBI SECURITIES CO., LTD. added 1,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,890
- TOWER RESEARCH CAPITAL LLC (TRC) added 479 shares (+479.0%) to their portfolio in Q2 2025, for an estimated $2,821
- GEODE CAPITAL MANAGEMENT, LLC added 225 shares (+1.1%) to their portfolio in Q2 2025, for an estimated $1,325
- UBS GROUP AG removed 126 shares (-99.2%) from their portfolio in Q2 2025, for an estimated $742
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
